Wordt geladen...
The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines
BACKGROUND: Subsidised access to high-cost medicines in Australia is restricted under national programs (the Pharmaceutical Benefits Scheme, PBS, and the Repatriation Pharmaceutical Benefits Scheme, RPBS) with a view to achieving cost-effective use. The aim of this study was to examine the use and a...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2007
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1828161/ https://ncbi.nlm.nih.gov/pubmed/17331230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-8462-4-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|